The BIN1 gene helps cells shape and recycle parts of their outer membrane, especially in muscle and brain cells, and if it does not work properly, muscle fibers may lose their usual structure and strength. This gene plays an important role in keeping muscle cells organized, so harmful variants can cause centronuclear myopathy, a condition that often leads to muscle weakness. Some common BIN1 variants are also linked to a higher chance of Alzheimer disease, but they do not mean a person will develop dementia.
What is a gene?
A gene is a stretch of DNA that carries instructions your cells use to make molecules or regulate processes in the body. Some genes hold the directions for producing proteins, the parts of cells that do much of the work. Others mainly control when certain processes happen, where they take place, and how active they are. Taken together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. To explore this subject in more detail, you can learn more in the LearnHub.
Overview
BIN1Gene function
What if the gene works
The BIN1 gene helps cells shape and remodel their outer membrane. This supports nerve cell communication and helps muscle cells form the inward folds needed for normal contraction.
Risk
What if the gene does not work
More disruptive variants in the BIN1 gene can cause centronuclear myopathy, with muscle weakness ranging from mild adult onset to severe infant disease with breathing problems. Common BIN1 variants are also linked to higher Alzheimer disease risk.
Treatment
What does that mean for your treatment
No treatment or management approach specific to the BIN1 gene is currently established. The BIN1 gene is also being studied in early-stage research in muscle conditions and as a biomarker in some cancers and Alzheimer disease.
Conditions associated with BIN1
Gene function
What if the gene works
Your cells use the BIN1 gene to shape parts of their outer membrane and move small packages to the right place. In muscle, it also helps build deep membrane folds that let signals spread through the whole cell. This day to day work is a key part of BIN1 gene function in muscle cells and other tissues.
BIN1 helps bend the cell membrane into gentle curves and narrow tubes. This gives cells the shape changes they need to organize busy membrane areas and move material efficiently.
BIN1 helps form and manage small membrane pockets and vesicles, which are tiny sacs that carry cargo inside cells. This supports routine recycling of membrane parts and helps surface proteins move to the right place.
In muscle cells, BIN1 helps build and maintain T-tubules, which are deep folds of the cell membrane. These folds carry electrical signals inward so the whole muscle cell can contract in a coordinated way.
What is a variant?
A genetic variant is a small difference in the DNA sequence within a gene. These differences are common and help create normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some situations, however, a variant can change how a gene works more significantly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the BIN1 gene can affect muscle cell membrane remodeling by changing the amphiphysin 2 protein’s shape, stability, or ability to bind membranes and partner proteins. Some missense variants leave partial activity, while splice, truncating, or more disruptive variants can markedly reduce protein production or remove key working regions. In BIN1 related centronuclear myopathy, this range in functional impact can influence how early features appear and how marked they are.
How variants are linked to conditions
Among BIN1 variants linked to conditions, the strongest evidence is for rare variants that cause centronuclear myopathy, a muscle condition that can lead to weakness from birth or later in life. Some common changes in the BIN1 gene are also associated with a slightly higher risk of Alzheimer disease in large population studies, but these risk markers do not make the condition certain.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are widespread in the general population. Most do not directly affect health and simply reflect normal human diversity. For many genes, having a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when several genes and environmental factors also play a part. In some situations, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
Some BIN1 changes are linked with a higher chance of late-onset Alzheimer’s disease, but they do not make it certain that someone will develop it. Overall risk is also shaped by age, family history, and common brain and heart health factors such as high blood pressure, diabetes, smoking, and low physical activity.
Inheritance of BIN1 variants
How BIN1 gene variants are inherited depends on the specific BIN1 related condition. For centronuclear myopathy linked to the BIN1 gene, both autosomal recessive and autosomal dominant inheritance have been documented. In autosomal recessive families, a child inherits one altered copy from each parent, while in autosomal dominant families, one altered copy from either parent can be enough to cause the condition. This means BIN1 inheritance can differ within the same gene depending on the variant and the clinical picture.
What does my BIN1 result mean for my family?
BIN1 results can have different family implications because this gene is linked to inherited muscle conditions that may run in families in either a dominant or recessive way. In some families, close relatives such as a parent, brother, sister, or child may also carry the same change and could have symptoms or pass it on. In other families, parents may be healthy carriers, and brothers or sisters may also be carriers or be affected. Some dominant BIN1 changes can also happen new in one person, without either parent carrying them.
Genetic information
Genetic testing
How you find out about variants
To look for variants in the BIN1 gene, genetic testing reads DNA from a blood sample, saliva, or a cheek swab. Genetic testing for BIN1 gene variants usually checks the gene directly, either on its own or as part of a larger test, to see whether a variant may help explain symptoms or a family pattern.
When should I consider getting a genetic test?
Genetic testing for BIN1 may be worth considering if there is unexplained muscle weakness from birth or childhood, low muscle tone, delayed motor milestones, or a family history of an inherited muscle condition such as centronuclear myopathy. A BIN1 test can help confirm the cause when this pattern fits.
A genetic result is only one part of your health story
Genetic test results can provide useful insight, but how much they reveal varies by the condition and the specific type of variant. Over time, many factors influence how the body functions, including lifestyle, environment, age, and medical history. In some conditions, particularly those shaped by many genes, genetic information provides context rather than certainty and is most helpful when viewed together with other parts of care. In other situations, a genetic result can offer a clear answer. In areas like medication response, genetic findings can also help make sense of an individual’s experience.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. One person may break down a drug more slowly, while another may process it faster or be more sensitive to its effects. This is a common reason the same treatment can work better for some people than for others, or cause more side effects in some than in others. In this way, inherited differences can shape both how well a medicine works and how your body handles it.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in a person’s genes can affect the way they respond to medications. It studies gene and drug patterns to help explain why the same treatment may work differently in different people. With many medicines, genes can influence how much effect a drug has or how the body handles it. This information can support treatment choices that are more informed and more tailored to the individual. More detailed information about this topic is available in the LearnHub.
Drugs influenced by the BIN1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in predicting how medicines will work or what side effects they may cause. Questions about your health, treatment options, or any new or worsening medicine side effects are best discussed with your doctor or pharmacist.
History
BIN1 entered the scientific literature in the 1990s, when researchers identified it while studying proteins that interact with MYC, a well known cancer related gene. Early work gave it more than one name, including amphiphysin II, reflecting how different research groups approached the same gene from different angles. Over time, descriptions became more precise as scientists recognized that these findings pointed to one gene with several forms. In the 2000s, interest widened when BIN1 variants were linked to inherited muscle conditions, including centronuclear myopathy. A further turning point came in large genetic studies of Alzheimer disease, where BIN1 emerged as one of the more consistently reported risk linked genes. Each stage in history has added to the picture we have today.